Call Today: 800-889-3898
Contact us for free information or to start a free case review.
All Digitek digoxin tablets on the U.S. market were recalled by their manufacturer, Actavis, in late April 2008. According to the Food and Drug Administration, a manufacturing mistake led to some of the Digitek digoxin tablets being made with twice the intended level of the active ingredient, digoxin (digitalis).
The double dose of digoxin in the tablets is toxic. Digitalis is a very powerful chemical; even its source, the flowering plant foxglove (Digitalis purpurea), is poisonous. Digitek digoxin tablets are a prescription-only treatment for heart conditions such as irregular heart beat and heart failure.
Although the generic drug digoxin is sold by various pharmaceutical companies under different names (such as Lanoxin and Digitek) and in various forms (tablet, elixir, liquid-filled capsules, intravenous injection), it is only the Digitek digoxin tablets that were recalled. All lots and all dosage strengths of the Digitek digoxin tables were recalled.
The nationwide Digitek recall was of the Digitek tablets distributed by UDL Laboratories under the label “UDL” and Mylan Pharmaceuticals under the label “Bertek.” If you as a patient have been prescribed either of these brands of Digitek digoxin tablets, contact your physician immediately.
If you’ve been treated with Digitek, you should also be aware of the potential adverse Digitek side effects:
Report any of these symptoms to your physician as soon as possible, or go to an emergency room for an evaluation.
Digoxin is also known as digitalis, which is a purified chemical extracted from the foxglove plant. Digoxin (the generic name of Digitek) is very widely used in the U.S. to treat heart conditions such as:
If you have taken Digitek digoxin tablets for any of the above or other conditions and have suffered a severe side effect, contact an experienced Digitek lawyer today to learn more about your rights.
Copyright © 2001 - 2010 Online Lawyer Source | Legal Marketing Site Designed by eJustice